NEW YORK, March 20 – Beckman Coulter announced Tuesday a reorganization plan, including the establishment of three new biomedical testing divisions.

The Fullerton, Calif.-based company said its biomedical testing operations would now be organized into the life science research division, the specialty testing division, and the clinical diagnostics division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.